PONLIMSI Trademark

Trademark Overview


On Tuesday, December 13, 2022, a trademark application was filed for PONLIMSI with the United States Patent and Trademark Office. The USPTO has given the PONLIMSI trademark a serial number of 97715304. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, December 19, 2023. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The PONLIMSI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
ponlimsi

General Information


Serial Number97715304
Word MarkPONLIMSI
Filing DateTuesday, December 13, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, December 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateFriday, December 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 18, 2023EXAMINER'S AMENDMENT ENTERED
Monday, September 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 18, 2023EXAMINERS AMENDMENT E-MAILED
Monday, September 18, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 12, 2023ASSIGNED TO EXAMINER
Friday, December 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 16, 2022NEW APPLICATION ENTERED